|
⚲
|
| Keyboard |
| PostFinance AG
✚
|
|
|---|---|
| CIK # | 0001727276 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001727276] | |
| 4 | [0001727276] | |
| SC 13G | [0001727276] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Postfinance AG | Cytori Therapeutics Inc | [2018-02-01] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| PostFinance AG | |
| Plus Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Plus Therapeutics Inc CYTX
Common Stock
|
2018-02-14 | Sell | 473,831 | $0.34 | 161,103 |
|
Plus Therapeutics Inc CYTX
Common Stock
|
2018-02-13 | Sell | 101,710 | $0.31 | 31,530 |
|
Plus Therapeutics Inc CYTX
Common Stock
|
2018-02-12 | Sell | 185,272 | $0.31 | 57,434 |
|
Plus Therapeutics Inc CYTX
Common Stock
|
2018-02-09 | Sell | 7,552 | $0.34 | 2,568 |
|
Plus Therapeutics Inc CYTX
Common Stock
|
2018-02-08 | Sell | 228,603 | $0.34 | 77,725 |